{"name":"isRed Pharma & Biotech Research Corporation","slug":"isred-pharma-biotech-research-corporation","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Nexium powder for injection and infusion 40 mg","genericName":"Nexium powder for injection and infusion 40 mg","slug":"nexium-powder-for-injection-and-infusion-40-mg","indication":"Other","status":"marketed"}]}],"pipeline":[{"name":"Nexium powder for injection and infusion 40 mg","genericName":"Nexium powder for injection and infusion 40 mg","slug":"nexium-powder-for-injection-and-infusion-40-mg","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMirgFBVV95cUxPNVhXeUVBTG5YV014SkI5SE9IMlUtN3B1VzJjS2dOQS1rb2F4VmNnQzFwdVdtaHdkd2VlbzN6U0dEcTF2VDNQWjRrZmgzWkx3NHdBYXVaNFVmX3pLMlRXdUk5LUo4em11R3BsLU0zbERLU3hGY1Rfc3NtV3hUNzk3bHF5N3RwWXczLUlHRUxnR3pveWJJdVl5MUN2ZjgtX3RVNHZRNld4UURMWWRGaGc?oc=5","date":"2025-09-09","type":"pipeline","source":"BioPharma APAC","summary":"The State of Biotech and Life Science Jobs in Asia Pacific – 2025 - BioPharma APAC","headline":"The State of Biotech and Life Science Jobs in Asia Pacific – 2025","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisgFBVV95cUxQbE1YeDVVa2R4WWVONEx1OUJCUHVWSllacHJBdXZWTnBoUm4tNUNBM1dzV0lPVU9LSURKekE5N1pEbk8wZG8tOGRidVJXRFpmdWlteTBRdmU0UG5xT2FpOVFUUFBzcmJrRFpPa2I1dERMc3VoQ2NKakNCTkdGS2JVSDE5bUcybE41R2F6MG50QXR3UE9TYVZNR1lPc2tJU3NIT2RBNm9rdUVZTEFEeVVMMFB3?oc=5","date":"2020-09-17","type":"pipeline","source":"GeekWire","summary":"Athira Pharma prices IPO at $17/share, will raise $204M in third Washington state IPO of 2020 - GeekWire","headline":"Athira Pharma prices IPO at $17/share, will raise $204M in third Washington state IPO of 2020","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiakFVX3lxTE1OUG12OUdFenAydGdxSE9xQjdyNTdFc1hSWmV4dWtwVHVGVnRKc2MzdENjek1id2ZaYU8yOWdwUmJUQ2tXU0RVUVJZLVlXX09LeGNCSkRnVUpGVnFRQy00RlM3QnpsM1ZvV1E?oc=5","date":"2020-08-26","type":"pipeline","source":"GeekWire","summary":"Seattle's Athira Pharma files for IPO to fund quest for Alzheimer’s and Parkinson’s breakthroughs - GeekWire","headline":"Seattle's Athira Pharma files for IPO to fund quest for Alzheimer’s and Parkinson’s breakthroughs","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMicEFVX3lxTFBVTUpvM0lWOURrRGxBLUtuMndxME51Umg0bVM1SUY5UVBJMDVGVldfRTRDc2dHQTE1NXk2RmpuY2lXbDUzb2Q2eWxacl9Qem03UnVYODJHN3RfeTdLaXNpdlItTVpRUk8tc0tHeHpIM1I?oc=5","date":"2018-09-28","type":"pipeline","source":"Business Insider","summary":"The market for biotech IPOs is red hot — here are the top 10 of 2018 - Business Insider","headline":"The market for biotech IPOs is red hot — here are the top 10 of 2018","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"marketed":1},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}